These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 32084574

  • 1. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
    Alshweiat A, Csóka I, Tömösi F, Janáky T, Kovács A, Gáspár R, Sztojkov-Ivanov A, Ducza E, Márki Á, Szabó-Révész P, Ambrus R.
    Int J Pharm; 2020 Apr 15; 579():119166. PubMed ID: 32084574
    [Abstract] [Full Text] [Related]

  • 2. Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation.
    Alshweiat A, Katona G, Csóka I, Ambrus R.
    Eur J Pharm Sci; 2018 Sep 15; 122():94-104. PubMed ID: 29908301
    [Abstract] [Full Text] [Related]

  • 3. Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability.
    Singh MK, Pooja D, Ravuri HG, Gunukula A, Kulhari H, Sistla R.
    Phytomedicine; 2018 Feb 01; 40():48-54. PubMed ID: 29496174
    [Abstract] [Full Text] [Related]

  • 4. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK, Patel MH, Patel K.
    Drug Dev Ind Pharm; 2016 Feb 01; 42(5):758-68. PubMed ID: 26548349
    [Abstract] [Full Text] [Related]

  • 5. Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism.
    Rana P, Murthy RS.
    Drug Deliv; 2013 Feb 01; 20(5):224-35. PubMed ID: 23651066
    [Abstract] [Full Text] [Related]

  • 6. A simple and low-energy method to prepare loratadine nanosuspensions for oral bioavailability improvement: preparation, characterization, and in vivo evaluation.
    Yang D, Li R, Zhang F, Qin L, Peng F, Jiang S, He H, Lu X, Zhang P.
    Drug Deliv Transl Res; 2020 Feb 01; 10(1):192-201. PubMed ID: 31482518
    [Abstract] [Full Text] [Related]

  • 7. Preparation, Characterization and In Vivo Assessment of Repaglinide Nanosuspension for Oral Bioavailability Improvement.
    Zawar LR, Bari SB.
    Recent Pat Drug Deliv Formul; 2018 Feb 01; 12(3):162-169. PubMed ID: 30003863
    [Abstract] [Full Text] [Related]

  • 8. Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability.
    Nagaraj K, Narendar D, Kishan V.
    Drug Dev Ind Pharm; 2017 Jul 01; 43(7):1186-1196. PubMed ID: 28271908
    [Abstract] [Full Text] [Related]

  • 9. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
    Zhang X, Zhang T, Lan Y, Wu B, Shi Z.
    AAPS PharmSciTech; 2016 Apr 01; 17(2):400-8. PubMed ID: 26187778
    [Abstract] [Full Text] [Related]

  • 10. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S, Reddy VA, Arora S, Patel K.
    Drug Deliv Transl Res; 2016 Oct 01; 6(5):498-510. PubMed ID: 27129488
    [Abstract] [Full Text] [Related]

  • 11. Intranasal Zotepine Nanosuspension: intended for improved brain distribution in rats.
    Pailla SR, Talluri S, Rangaraj N, Ramavath R, Challa VS, Doijad N, Sampathi S.
    Daru; 2019 Dec 01; 27(2):541-556. PubMed ID: 31256410
    [Abstract] [Full Text] [Related]

  • 12. Preparation of loratadine nanocrystal tablets to improve the solubility and dissolution for enhanced oral bioavailability.
    Li J, Zhou Y, Aisha M, Wu J, Wang H, Huang F, Sun M.
    J Pharm Pharmacol; 2021 Jun 08; 73(7):937-946. PubMed ID: 33963858
    [Abstract] [Full Text] [Related]

  • 13. Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation.
    Allam AN, Hamdallah SI, Abdallah OY.
    Int J Nanomedicine; 2017 Jun 08; 12():4733-4745. PubMed ID: 28740381
    [Abstract] [Full Text] [Related]

  • 14. Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine.
    Chen Y, Liu Y, Xie J, Zheng Q, Yue P, Chen L, Hu P, Yang M.
    Int J Nanomedicine; 2020 Jun 08; 15():10435-10451. PubMed ID: 33380794
    [Abstract] [Full Text] [Related]

  • 15. Novel self-nanoemulsifying self-nanosuspension (SNESNS) for enhancing oral bioavailability of diacerein: Simultaneous portal blood absorption and lymphatic delivery.
    El-Laithy HM, Basalious EB, El-Hoseiny BM, Adel MM.
    Int J Pharm; 2015 Jul 25; 490(1-2):146-54. PubMed ID: 26002566
    [Abstract] [Full Text] [Related]

  • 16. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
    Patel PJ, Gajera BY, Dave RH.
    Drug Dev Ind Pharm; 2018 Dec 25; 44(12):1942-1952. PubMed ID: 30027778
    [Abstract] [Full Text] [Related]

  • 17. Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design.
    Kassem MAA, ElMeshad AN, Fares AR.
    AAPS PharmSciTech; 2017 May 25; 18(4):983-996. PubMed ID: 27506564
    [Abstract] [Full Text] [Related]

  • 18. Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition.
    Rahim H, Sadiq A, Khan S, Amin F, Ullah R, Shahat AA, Mahmood HM.
    Int J Nanomedicine; 2019 May 25; 14():6287-6296. PubMed ID: 31496686
    [Abstract] [Full Text] [Related]

  • 19. Enhanced bioavailability of cinnarizine nanosuspensions by particle size engineering: Optimization and physicochemical investigations.
    Mishra B, Sahoo J, Dixit PK.
    Mater Sci Eng C Mater Biol Appl; 2016 Jun 25; 63():62-9. PubMed ID: 27040196
    [Abstract] [Full Text] [Related]

  • 20. Preparation, characterization and pharmacokinetics of cyadox nanosuspension.
    Sattar A, Chen D, Jiang L, Pan Y, Tao Y, Huang L, Liu Z, Xie S, Yuan Z.
    Sci Rep; 2017 May 23; 7(1):2289. PubMed ID: 28536446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.